Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

Josbert J Keller; Maria Jgt Vehreschild; Christian L Hvas; Simon Md Jørgensen; Jouzas Kupciskas; Alexander Link; Chris Jj Mulder; Simon D Goldenberg; Ramesh Arasaradnam; Harry Sokol; Antonio Gasbarrini; Christoph Hoegenauer; Elizabeth M Terveer; Ed J Kuijper; Perttu Arkkila; UEG working group of the Standards and Guidelines initiative Stool banking for FMT

doi:10.1177/2050640619887579

Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

United European Gastroenterol J. 2019 Dec;7(10):1408-1410. doi: 10.1177/2050640619887579. Epub 2019 Nov 14.

Authors

Josbert J Keller^{1

2}, Maria Jgt Vehreschild³, Christian L Hvas⁴, Simon Md Jørgensen⁴, Jouzas Kupciskas⁵, Alexander Link⁶, Chris Jj Mulder⁷, Simon D Goldenberg⁸, Ramesh Arasaradnam⁹, Harry Sokol^{10

11

12}, Antonio Gasbarrini¹³, Christoph Hoegenauer¹⁴, Elizabeth M Terveer^{15

2}, Ed J Kuijper^{16

2}, Perttu Arkkila¹⁷; UEG working group of the Standards and Guidelines initiative Stool banking for FMT

Affiliations

¹ Department of Gastroenterology, Haaglanden Medical Center, The Hague, The Netherlands, and Leiden University Medical Center, Leiden, The Netherlands.
² Netherlands Donor Feces Bank, Leiden University Medical Center.
³ University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, Frankfurt am Main, Germany.
⁴ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
⁵ Department of Gastroenterology and Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
⁶ Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany.
⁷ Chris Mulder, Department of Gastroenterology, Free University Medical Center, Amsterdam, The Netherlands.
⁸ Centre for Clinical Infection and Diagnostics Research (CIDR), King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, UK.
⁹ Warwick Medical School, University of Warwick, Coventry, UK.
¹⁰ Sorbonne Université, INSERM, Saint-Antoine Research Center (CRSA), Paris, France.
¹¹ French Group of Fecal Microbiota Transplantation (GFTF).
¹² INRA, UMR1319 Micalis, AgroParisTech, Jouy-en-Josas, France.
¹³ Gastroenterology Area, Fondazione Policlinico Universitario Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
¹⁴ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
¹⁵ Department of Medical Microbiology and Netherlands Donor Feces Bank, Leiden University Medical Centre, Leiden, The Netherlands.
¹⁶ Centre for Microbiota Analysis and Therapeutics, Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
¹⁷ Helsinki University Hospital and Helsinki University, Helsinki, Finland.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Enterocolitis, Pseudomembranous / microbiology
Enterocolitis, Pseudomembranous / therapy
Fecal Microbiota Transplantation* / methods
Fecal Microbiota Transplantation* / standards
Feces / microbiology*
Humans
Transplants